Tempest Therapeutics, Inc.

8-K Shareholder vote results; Other events Jul 28, 2026 8-K Entered a material agreement; Regulation FD disclosure Jul 22, 2026 8-K Shareholder vote results Jun 23, 2026 8-K Director or officer change; Regulation FD disclosure Jun 4, 2026 8-K Entered a material agreement; Unregistered sale of equity Jun 2, 2026 8-K Director or officer change May 29, 2026 8-K Delisting notice or listing-rule failure May 22, 2026 8-K Director or officer change May 22, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release) May 14, 2026 8-K Regulation FD disclosure; Other events May 6, 2026 10-K Fiscal year ended 2025-12-31 Mar 30, 2026 8-K Results of operations (earnings release) Mar 30, 2026 8-K Entered a material agreement; Unregistered sale of equity Mar 23, 2026 8-K Regulation FD disclosure; Other events Feb 25, 2026 8-K Regulation FD disclosure Feb 11, 2026 8-K Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Change in control; Director or officer change Feb 6, 2026 8-K Modified rights of security holders; Director or officer change; Shareholder vote results Jan 28, 2026 8-K Delisting notice or listing-rule failure Jan 9, 2026 8-K Unregistered sale of equity; Other events Nov 26, 2025 8-K Entered a material agreement; Unregistered sale of equity; Director or officer change; Other events Nov 19, 2025 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release) Nov 5, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Results of operations (earnings release) Aug 11, 2025 8-K Entered a material agreement; Regulation FD disclosure; Other events Jun 12, 2025 8-K Other events Jun 11, 2025 8-K Director or officer change Jun 6, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Results of operations (earnings release) May 13, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 30, 2025 8-K Other events Apr 28, 2025 8-K Exit or disposal costs Apr 18, 2025 8-K Terminated a material agreement; Regulation FD disclosure Apr 9, 2025 8-K Modified rights of security holders Apr 7, 2025 10-K Fiscal year ended 2024-12-31 Mar 27, 2025 8-K Results of operations (earnings release) Mar 27, 2025 8-K Delisting notice or listing-rule failure Dec 31, 2024 8-K Entered a material agreement; Modified rights of security holders; Shareholder vote results Dec 6, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024